Goldman Sachs Income Fund Class A Shares (GSCHX US) stock market data APIs
9.2001
0(0%)
as of June 30, 2025
Try our APIs with
free plan!
Goldman Sachs Income Fund Class A Shares Financial Data Overview
Price chart is built with
Anychart
Prev. Close
9.2001
Open
9.2001
High
9.2001
Low
9.2001
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Goldman Sachs Income Fund Class A Shares data using free add-ons & libraries
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get Goldman Sachs Income Fund Class A Shares End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Goldman Sachs Income Fund Class A Shares News
New
Thermo Fisher Scientific's (NYSE:TMO) earnings growth rate lags the 34% CAGR delivered to shareholders
Long term investing can be life changing when you buy and hold the truly great businesses. And we've seen some truly amazing gains over the years. Don't believe it? Then look at the Thermo Fisher Scie...
Murphy Capital Management Inc Buys Thermo Fisher Scientific Inc, NVIDIA Corp, Schwab U.S. ...
Gladstone, NJ, based Investment company Murphy Capital Management Inc (Current Portfolio) buys Thermo Fisher Scientific Inc, NVIDIA Corp, Schwab U.S. Large-Cap ETF, FactSet Research Systems Inc, Netfl...
Voya VARIABLE FUNDS Buys PNC Financial Services Group Inc, McDonald's Corp, Baxter ...
Investment company Voya VARIABLE FUNDS (Current Portfolio) buys PNC Financial Services Group Inc, McDonald's Corp, Baxter International Inc, ViacomCBS Inc, Bank of America Corp, sells Fiserv Inc, Citi...
Rtw Investments, Lp Buys Thermo Fisher Scientific Inc, Penumbra Inc, Tenaya Therapeutics Inc, ...
Investment company Rtw Investments, Lp (Current Portfolio) buys Thermo Fisher Scientific Inc, Penumbra Inc, Tenaya Therapeutics Inc, argenx SE, Macrogenics Inc, sells Quidel Corp, Protagonist Therapeu...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
